Navigation Links
Biological therapy with cediranib improves survival in women with recurrent ovarian cancer
Date:9/30/2013

Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results to be presented today (Monday) at the 2013 European Cancer Congress (ECC2013) [1].

Cediranib, which is taken in pill form, is an inhibitor of a cell signalling process involved in formation of tumour blood vessels, essential for tumour growth, and it is the first oral inhibitor of its kind to show an improvement in the time before patients' disease progresses and in overall survival. The drug is a tyrosine kinase inhibitor, a type of biological therapy that blocks vascular endothelial growth factor (VEGF) receptors, which control the development of blood vessels required for growing tumours.

Professor Jonathan Ledermann, Professor of Medical Oncology at UCL Cancer Institute, University College London, presented first results from ICON6, an international randomised, double-blind, academic clinical phase III trial of cediranib.

"In women whose ovarian cancer had been treated with platinum-based chemotherapy together with cediranib given during and after the chemotherapy, we found that the time before the tumour started to grow again was extended by an average of 3.2 months. This sounds like a modest increase but represents about a 30% improvement, with overall survival also increased by a similar amount, to an average of 2.7 months over a two-year period of follow-up," he said.

Studies with chemotherapy alone have shown that the time before patients experience disease progression following treatment for a relapse that is sensitive to platinum-based chemotherapy is an average of eight to nine months. These latest results show that cediranib in addition to chemotherapy increased the time before the disease progressed from 9.4 to 12.6 months over a period of two years, and it extended overall survival from 17.6 to 20.3 months.

"These are ground-brea
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Religious leaders can be key to biological diversity
2. Single-cell transfection tool enables added control for biological studies
3. Biological activity alters the ability of sea spray to seed clouds
4. Epigenetic changes shed light on biological mechanism of autism
5. PeerJ launches PeerJ PrePrints -- a preprint server for the biological and medical sciences
6. Declaring a truce with our microbiological frienemies
7. UMass Amherst researchers reveal mechanism of novel biological electron transfer
8. Biological wires carry electricity thanks to special amino acids
9. Wayne State University researchers techniques enable more, faster testing of biological liquids
10. Snooze button on biological clocks improves cell adaptability
11. Advance promises to expand biological control of crop pests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... Northeastern University researchers and their international colleagues have ... role of neutral evolution in the biogeographic distribution ... Thursday in the journal Science . The ... a neutral agent-based model"was co-authored by Ferdi Hellweger, ... of civil and environmental engineering; his doctoral student ...
(Date:9/11/2014)... Sept. 11, 2014 /PRNewswire-iReach/ -- Today at the TEDMED ... patient portal that puts genome sequencing results at the ... and actionable. The $1000 was announced earlier ... to be the tipping point towards widespread adoption of ... billion letters and 4 million variants per human genome, ...
(Date:9/11/2014)... 2014 NXT-ID, Inc. (Nasdaq: NXTD ), ... market, announced today that its shares of common stock and ... Nasdaq Capital Market. The common stock and warrants and will ... today, the Company,s common stock will no longer be quoted ... will now be traded on Nasdaq. About ...
Breaking Biology News(10 mins):Microbes evolve faster than ocean can disperse them 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 2Tute Genomics Launches MyGene Portal for Genome-guided Medicine 3
... irritants such as air pollution and cigarette smoke cause people ... Journal of Respiratory and Critical Care Medicine . The authors ... of Hull, have identified the reaction inside the lungs that ... irritants in the air. They suggest that their findings may ...
... release is available in German . ... in the atmosphere where it contributes to global warming. The ... as forests, grasslands and peat-lands. Stimulating this "free service" of ... immediately available ways of reducing climate change. However, new greenhouse ...
... A butterfly,s proboscis looks like a straw -- long, slender, ... a paper towel, according to Konstantin Kornev of Clemson University. ... insect anatomy to make small probes that can sample the ... next week at the 62nd Annual Meeting of the American ...
Cached Biology News:Research reveals exactly how coughing is triggered by environmental irritants 2Intensive land management leaves Europe without carbon sinks 2
(Date:9/11/2014)... 2014 The Registration Committee today ... now open for Pittcon 2015, the world’s largest ... event will be held March 8-12, 2015, at ... , The discounted registration fee of $175 ... 2/20/2015). This affordable price includes unlimited week-long access ...
(Date:9/11/2014)... /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") ... it intends to conduct a Private Placement to ... its preclinical development activities and financial commitments to ... The Company is proposing to complete a non-brokered ... at a price of US$0.10 per Share, for ...
(Date:9/11/2014)... Awarded annually by Germany’s Design Zentrum Nordrhein-Westfalen, ... quality label for excellent design. METTLER TOLEDO is ... Red Dot award in recognition of high ... (HPD). , The Quantos Handheld Powder Dispenser ... to applications involving free-flowing powders. Forget the delicacy ...
(Date:9/11/2014)... and LONDON , ... Cancer Research Technology (CRT), the charity,s development and ... (OTCBB: ASTY), a biotechnology company in the emerging ... novel immunotherapy treatment AST-VAC2 into clinical trials in ... AST-VAC2 represents the tenth treatment to enter Cancer ...
Breaking Biology Technology:Conferee Registration Opens for Pittcon 2015; Housing & Travel Open for Reservations 2Portage Announces Proposed Private Placement 2Portage Announces Proposed Private Placement 3Portage Announces Proposed Private Placement 4METTLER TOLEDO Handheld Powder Receives Red Dot Award for Product Design 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 4Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 5Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 6Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 7Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 8
... Ariz., April 4, 2012  MedPlast, Inc., a technology ... Healthcare and Industrial specialty markets, announces the acquisition ... a world-class, full-service manufacturer of precision plastic products ... Datacenter markets, with operations in the U.S., China, ...
... Lian, assistant professor in the Department of Mechanical, Aerospace, ... a prestigious Faculty Early Career Development Award (CAREER) from ... the five-year, $500,000 award to further his research into ... systems. The CAREER Award is given to faculty members ...
... April 3, 2012  Oxford Finance LLC ("Oxford"), a specialty ... and healthcare services companies, today announced a $15 million ... The financing package, which was awarded to NanoString from ... million senior secured term loan and a $2 million ...
Cached Biology Technology:MedPlast Acquires UPG 2MedPlast Acquires UPG 3Rensselaer professor Jie Lian receives NSF CAREER Award 2Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies 2Oxford Finance and Silicon Valley Bank Provide $15 Million Senior Credit Facility to NanoString Technologies 3
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
Biology Products: